Byoung Chul Cho - Dissemin

Language
Login

Papers authored by Byoung Chul Cho

This paper was not found in any repository, but could be made available legally by the author.

2021 Sun Min Lim, Kyoung-Ho Pyo

ORCID

, Ross A. Soo, Byoung Chul Cho

ORCID

The promise of bispecific antibodies: Clinical applications and challenges

Upload

This paper was not found in any repository, but could be made available legally by the author.

Jong-Mu Sun, Lin Shen, Manish A. Shah, Peter Enzinger, Antoine Adenis, Toshihiko Doi, Takashi Kojima, Jean-Philippe Metges, Zhigang Li, Sung-Bae Kim, Byoung Chul Cho

ORCID

, Wasat Mansoor, Shau-Hsuan Li, Patrapim Sunpaweravong, Maria Alsina Maqueda and 10 other authors

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

Upload

This paper was not found in any repository, but could be made available legally by the author.

Beung-Chul Ahn

ORCID

, Jea-Woo So, Chun-Bong Synn, Tae Hyung Kim, Jae Hwan Kim, Yeongseon Byeon, Young Seob Kim, Seong Gu Heo

ORCID

, San-Duk Yang, Mi Ran Yun

ORCID

ORCID

, Su-Jin Choi, Wongeun Lee, Dong Kwon Kim

ORCID

, Eun Ji Lee and 8 other authors

Clinical decision support algorithm based on machine learning to assess the clinical response to anti–programmed death-1 therapy in patients with non–small-cell lung cancer

Upload

This paper is made freely available by the publisher.

Beung-Chul Ahn

ORCID

, Jee Kim

ORCID

, Kyoung-Ho Pyo, Sun Lim, Min Hong

ORCID

, Hye Kim, Byoung Cho

ORCID

Analyses of CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC from ASTRIS Korean Subset, Open-Label Real-World Study

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Justin F. Gainor, Giuseppe Curigliano, Dong-Wan Kim, Dae Ho Lee, Benjamin Besse, Christina S. Baik, Robert C. Doebele, Philippe A. Cassier, Gilberto Lopes, Daniel S. W. Tan, Elena Garralda

ORCID

, Luis G. Paz-Ares, Byoung Chul Cho

ORCID

, Shirish M. Gadgeel, Michael Thomas and 10 other authors

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study

Upload

This paper is made freely available by the publisher.

Beung-Chul Ahn, Ji Hyun Lee, Min Hwan Kim, Kyoung-Ho Pyo, Choong-Kun Lee, Sun Min Lim, Hye Ryun Kim, Byoung Chul Cho

ORCID

ORCID

Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Download from doi.org

This paper is made freely available by the publisher.

Vivek Subbiah

ORCID

, Justin F. Gainor, Geoffrey R. Oxnard, Daniel S. W. Tan, Dwight H. Owen

ORCID

, Byoung Chul Cho

ORCID

, Herbert H. Loong

ORCID

, Caroline E. McCoach, Jared Weiss, Yu Jung Kim

ORCID

, Lyudmila Bazhenova

ORCID

, Keunchil Park

ORCID

, Haruko Daga, Benjamin Besse, Oliver Gautschi and 6 other authors

Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

Download from aacrjournals.org

This paper is made freely available by the publisher.

Seok-Young Kim, Sang-Min Kim, Sumin Lim, Ji Yeon Lee

ORCID

, Su-Jin Choi, San-Duk Yang, Mi Ran Yun

ORCID

, Chang Gon Kim, Seo Rin Gu

ORCID

, Chaewon Park, A.-Young Park, Sun Min Lim, Seong Gu Heo

ORCID

, HyunKi Kim, Byoung Chul Cho

ORCID

Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma

Download from aacrjournals.org

This paper is made freely available by the publisher.

Sun Min Lim, San-Duk Yang, Sangbin Lim, Hyo Sup Shim, Byoung Chul Cho

ORCID

Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and Savolitinib

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Chang Gon Kim, Byoung Chul Cho

ORCID

, Sun Min Lim

Sequencing of MET Inhibitors in Lung Cancer: Have We Met the Target?

Upload

This paper was not found in any repository, but could be made available legally by the author.

Corinne Faivre-Finn, David Vicente, Takayasu Kurata, David Planchard, Luis Paz-Ares, Johan F. Vansteenkiste, David R. Spigel, Marina C. Garassino, Martin Reck, Suresh Senan, Jarushka Naidoo, Andreas Rimner, Yi-Long Wu, Jhanelle E. Gray, Mustafa Özgüroğlu and 8 other authors

Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial

Upload

This paper is made freely available by the publisher.

Rafal Dziadziuszko, Matthew G. Krebs

ORCID

, Filippo De Braud, Salvatore Siena, Alexander Drilon

ORCID

, Robert C. Doebele, Manish R. Patel, Byoung Chul Cho

ORCID

, Stephen V. Liu

ORCID

, Myung-Ju Ahn, Chao-Hua Chiu, Anna F. Farago

ORCID

ORCID

, Christos S. Karapetis, Yu-Chung Li

ORCID

and 4 other authors

Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or MetastaticROS1Fusion–Positive Non–Small-Cell Lung Cancer

Download from doi.org

This paper is made freely available by the publisher.

Joo-Young Im, Bo-Kyung Kim, Sung-Hoon Yoon, Byoung Chul Cho

ORCID

, Yu Mi Baek, Mi-Jung Kang, Nayeon Kim, Young-Dae Gong, Misun Won

DGG-100629 inhibits lung cancer growth by suppressing the NFATc1/DDIAS/STAT3 pathway

Download from www.nature.com

This paper is made freely available by the publisher.

Yeona Cho, Joongyo Lee, Ik Jae Lee, Jun Won Kim

ORCID

, Jong Geol Baek, Dong Min Jung, Byoung Chul Cho

ORCID

, Min Hee Hong, Hye Ryun Kim, Chang Geol Lee, Hong In Yoon

Intracranial failure after hippocampal-avoidance prophylactic cranial irradiation in limited-stage small-cell lung cancer patients

Download from www.nature.com

This paper is made freely available by the publisher.

Manish A. Shah

ORCID

, Jaafar Bennouna

ORCID

, Toshihiko Doi, Lin Shen, Ken Kato

ORCID

, Antoine Adenis, Harvey J. Mamon, Markus Moehler, Xiaolong Fu, Byoung Chul Cho

ORCID

, Sonal Bordia, Pooja Bhagia, Chie-Schin Shih, Anjali Desai, Peter Enzinger

KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Edward B. Garon, Byoung Chul Cho

ORCID

, Niels Reinmuth, Ki Hyeong Lee

ORCID

, Alexander Luft, Myung-Ju Ahn, Gilles Robinet, Sylvestre Le Moulec, Sylvestre Le Moulec, Ronald Natale, Jeffrey Schneider, Frances A. Shepherd, Marina Chiara Garassino, Sarayut Lucien Geater

ORCID

, Zsolt Papai Szekely and 6 other authors

Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non-Small Cell Lung Cancer (MYSTIC)

Upload

This paper is made freely available by the publisher.

Keunchil Park

ORCID

, Pasi A. Jӓnne, Dong‐Wan Kim, Ji‐Youn Han, Ming‐Fang Wu, Jong‐Seok Lee, Jin‐Hyoung Kang, Dae Ho Lee, Byoung Chul Cho

ORCID

, Chong‐Jen Yu

ORCID

, Yong Kek Pang, Enriqueta Felip, Hyunjin Kim, Eunhye Baek, Young Su Noh

Olmutinib in T790M‐positive non–small cell lung cancer after failure of first‐line epidermal growth factor receptor‐tyrosine kinase inhibitor therapy: A global, phase 2 study

Download from onlinelibrary.wiley.com

This paper is made freely available by the publisher.

2020 Julius Strauss, Margaret E. Gatti-Mays

ORCID

, Byoung Chul Cho

ORCID

, Andrew Hill, Sébastien Salas, Edward McClay, Jason M. Redman, Houssein A. Sater

ORCID

, Renee N. Donahue, Caroline Jochems

ORCID

, Elizabeth Lamping, Andrea Burmeister, Jennifer L. Marté, Lisa M. Cordes

ORCID

, Marijo Bilusic

ORCID

and 8 other authors

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

R. Perets, J. Bar, D. W. Rasco, M.-J. Ahn, K. Yoh, D.-W. Kim, A. Nagrial, M. Satouchi, D. H. Lee, D. R. Spigel, D. Kotasek, M. Gutierrez, J. Niu, S. Siddiqi, X. Li and 5 other authors

Safety and Efficacy of Quavonlimab, a Novel Anti–CTLA-4 Antibody (MK-1308), in Combination with Pembrolizumab in First-Line Advanced Non–Small Cell Lung Cancer

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Seong Yong Park, Min Hee Hong, Hye Ryun Kim, Chang Geol Lee, Jae Ho Cho, Byoung Chul Cho

ORCID

, Dae Joon Kim

The feasibility and safety of radical esophagectomy in patients receiving neoadjuvant chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma

Upload

Missing publications? Search for publications with a matching author name.